Dulcolax Bisacodyl 5mg tablets

Dulcolax is a well-known brand of laxative products used for the treatment of constipation. The active ingredient in this specific version, Bisacodyl, was first discovered in the 1950s by the German pharmaceutical company Boehringer Ingelheim. For several decades, the brand remained under their portfolio, becoming one of the most recognized over-the-counter gastrointestinal treatments globally.

In 2017, as part of a significant strategic asset swap, Boehringer Ingelheim transferred its consumer healthcare business, including Dulcolax, to the French pharmaceutical giant Sanofi. Today, Sanofi manages the brand through its dedicated consumer healthcare division. In recent corporate developments, Sanofi has taken steps to separate its consumer health business into a standalone entity named Opella to focus more on its core innovative biopharmaceutical pipeline.

Manufacturing for Dulcolax occurs in multiple locations across Europe and North America to serve different regional markets. Depending on the specific market—such as Australia, where this packaging is from (noted by the AUST R number)—the product is distributed by the local Sanofi subsidiary.